DiscoverDiscovery Matters90. Advanced therapies (Part 2)
90. Advanced therapies (Part 2)

90. Advanced therapies (Part 2)

Update: 2024-08-08
Share

Description

We're diving into advanced therapies with industry leaders. Emmanuel Abate, President of Genomic Medicine at Cytiva discussed the strategies to accelerate clinical work and reduce costs. Nathaniel Wang, CEO and Co-Founder of Replicate Bioscience highlighted their ground breaking self-replicating RNA technology, showcasing impressive clinical results for a rabies vaccine. Both experts emphasized the momentum in biotech, the potential of AI in advancing science, and the importance of making innovative therapies accessible globally. Stay tuned for these insights.


Show notes



Keywords: vaccines, advanced therapies, mRNA, manufacturing, technology, patients, innovation, new modalities.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

90. Advanced therapies (Part 2)

90. Advanced therapies (Part 2)

Discovery Matters